Recruiting

Observational Study

Sponsor:

Inspire Medical Systems, Inc.

Code:

NCT04457154

Conditions

Obstructive Sleep Apnea

Eligibility Criteria

Sex: All

Age: 18 - 21

Healthy Volunteers: Not accepted

Interventions

Inspire Upper Airway Stimulation System

Study Details

Brief summary:

This registry is a prospective, multi-center, single-arm study of pediatric subjects (ages 18-21 years) who are undergoing implant of the Inspire Upper Airway Stimulation (UAS) System for the treatment of moderate or severe obstructive sleep apnea (OSA). Implanted subjects will be followed for 5 years post-implant.

Conditions

Obstructive Sleep Apnea

Study ID

NCT04457154

Start date

Nov 30, 2021

Status verified date

Aug, 2024

Completion date

Apr, 2028

Anticipated

Primary completion date

Dec, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 21

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Subject is between 18 and 21 years of age;
2. Subject has a diagnosis of moderate to severe OSA (15 ≤ AHI ≤ 65) based on a recent sleep study;
3. Subject has documented failure of, or intolerance to, positive airway pressure treatments, despite attempts to improve compliance;
4. Subject is contraindicated for, or not effectively treated by, adenotonsillectomy;
5. Subject has followed standard of care in considering all other alternative/adjunct therapies;
6. Subject is willing and able to have stimulation hardware permanently implanted and to use the patient remote to activate the stimulation;
7. Subject is willing and able to return for follow-up visits, undergo sleep studies (including in-lab and at-home), and complete questionnaires related to the registry;
8. Subject is willing and able to provide informed consent.

Exclusion Criteria:

1. Subject has a combination of central + mixed apneas > 25% of the total apnea-hypopnea index (AHI);
2. Subject has any anatomical finding that would compromise the performance of upper airway stimulation, such as the presence of complete concentric collapse of the soft palate;
3. Subject has any condition or procedure that has compromised neurological control of the upper airway;
4. Subject is unable, or does not have the necessary assistance, to operate the patient remote;
5. Subject is pregnant or plans to become pregnant;
6. Subject has an implantable device that may be susceptible to unintended interaction with the Inspire System;
7. Subject has a terminal illness with life expectancy < 12 months;
8. Any other reason the investigator deems the subject is unfit for participation in the registry.

Study Design

Enrollment

60 participants

Anticipated

Interventions and Outcome Measures

Arms

Registry Population

Pediatric subjects (age 18-21 years) who are undergoing implant of the Inspire Upper Airway Stimulation System for the treatment of moderate to severe obstructive sleep apnea (OSA)

Interventions

Inspire Upper Airway Stimulation System

Implant of the Inspire Upper Airway Stimulation System

Primary outcome measure

  • Evaluation of device and/or procedure related adverse events over time [ Time Frame: Implant through 5 years post-implant ]
  • Evaluation of the improvement of Apnea Hypopnea Index (AHI) over time [ Time Frame: through 5 years post-implant ]

Central Contacts and Locations

Locations

Childrens Hospital of Colorado

Recruiting

Aurora, Colorado, United States, 80045

Contacts

Principal Investigator:

Norman Friedman, MD

Duke University

Recruiting

Durham, North Carolina, United States, 27705

Contacts

Principal Investigator:

Eileen Raynor, MD

Cincinnati Childrens Hospital

Recruiting

Cincinnati, Ohio, United States, 45229

Contacts

Principal Investigator:

David Smith, MD

Children's Hospital of Philadelphia

Recruiting

Philadelphia, Pennsylvania, United States, 19406

Contacts

Ashley Williams

williamsab@chop.edu

Principal Investigator:

Lisa Elden, MD

Children's Hospital of Pittsburgh

Recruiting

Sewickley, Pennsylvania, United States, 15143

Contacts

Amber Shaffer

shafferad@upmc.edu

Principal Investigator:

Rachel Whelan, MD

University of Texas Southwestern/Children's Hospital of Dallas

Recruiting

Dallas, Texas, United States, 75207

Contacts

Principal Investigator:

Ron Mitchell, MD

Children's Hospital of the King's Daughters/East Virginia Medical School

Recruiting

Norfolk, Virginia, United States, 23507

Contacts

Lakshya Enugu

enugul@evms.edu

Principal Investigator:

Cristina Baldassari, MD

More Information

Sponsor

Inspire Medical Systems, Inc.

Last update posted

Feb 25, 2025

Last verified

Aug, 2024

Keywords

  • Pediatric
  • Apnea-hypopnea Index
  • Sleep Breathing Disorders

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Inspire Medical Systems, Inc. on 2025-02-25.